B-CELL LYMPHOMA, UNSPECIFIED

Clinical trials for B-CELL LYMPHOMA, UNSPECIFIED explained in plain language.

Never miss a new study

Get alerted when new B-CELL LYMPHOMA, UNSPECIFIED trials appear

Sign up with your email to follow new studies for B-CELL LYMPHOMA, UNSPECIFIED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug cocktail tested for aggressive lymphomas

Disease control Ongoing

This early-stage study is testing a combination of three drugs—obinutuzumab, venetoclax, and lenalidomide—in patients whose B-cell non-Hodgkin lymphoma has come back or hasn't responded to previous treatments. The main goal is to find the safest and most effective dose of the dru…

Matched conditions: B-CELL LYMPHOMA, UNSPECIFIED

Phase: PHASE1 • Sponsor: Beth Christian • Aim: Disease control

Last updated Apr 01, 2026 21:56 UTC

B-CELL LYMPHOMA, UNSPECIFIED

Get alerted when new B-CELL LYMPHOMA, UNSPECIFIED trials appear

New drug cocktail tested for aggressive lymphomas